Explore

Healthy Living

News

Health A-Z

Calculators

Articles

Drugs

Directories

Education

More

Search Medindia

Medindia » Health Press Releases A-Z

Two Additional Private Payers Provide Coverage for Posterior Tibial Nerve Stimulation Delivered Using the Uroplasty Urgent® PC Neuromodulation System

Health Care Service Corporation and Blue Cross Blue Shield Nebraska Represent an Additional 13.7 Million Covered Lives


For Further Information:Uroplasty, Inc. David Kaysen, President and CEO, or Medi Jiwani, Vice President, CFO, Treasurer 952.426.6140	EVC Group Doug Sherk/Jenifer Kirtland (Investors), 415.896.6820 Chris Gale (Media), 646.201.5431

Sponsored Post and Backlink Submission

Latest Press Release on General News

OrthAlign Expands Lantern® Hip Platform to Support Posterior-Based Surgical Approaches in Total Hip Arthroplasty

PR Newswire IRVINE, Calif., Dec. 16, 2025 New software broadens market reach and enables surgeons to use Lantern Hip with their preferred surgical approach, including posterior-based...

Manual Recline Provides Invacare America Wheelchair Users a Simple, Practical Option for Pressure Relief

PR Newswire ELYRIA, Ohio and CONCORD, ON, Dec. 9, 2025 Motion Concepts mechanism now accessible to all customers ELYRIA, Ohio and CONCORD, ON, Dec. 9, 2025 /PRNewswire/ -- Gently...

Advita Ortho Wins Innovation Award for Soft Tissue Balancing in Knee Replacement Surgery

PR Newswire GAINESVILLE, Fla., Dec. 16, 2025 GAINESVILLE, Fla., Dec. 16, 2025 /PRNewswire/ -- Advita Ortho, a global medical technology leader, has been awarded the Innovation award ...

New Modeling Approach Sheds Light on Rare Gut Disease

PR Newswire NEW YORK, Dec. 16, 2025 NEW YORK, Dec. 16, 2025 /PRNewswire/ -- During development of the digestive system, a complex network of nerves forms around it, creating a "secon...

ADEL Signs $1.04 Billion Global License Agreement with Sanofi for ADEL-Y01, a Novel investigational Alzheimer's Disease Therapy

PR Newswire SEOUL, South Korea, Dec. 15, 2025 SEOUL, South Korea, Dec. 15, 2025 /PRNewswire/ -- ADEL, Inc., a biopharmaceutical company dedicated to developing therapies for neurodeg...

â¬†ï¸

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use Ok, Got it. Close